[1]丁凡,李宏伟,欧阳勤,等.二甲双胍激活AMPK/mTOR通路上调阴茎海绵体自噬增强老年ED大鼠勃起功能[J].第三军医大学学报,2020,42(11):1109-1115.
 DING Fan,LI Hongwei,OUYANG Qin,et al.Metformin enhances erectile function in rats with aging-induced erectile dysfunction by activatingAMPK/mTOR pathway-regulated autophagy in corpus cavernosum[J].J Third Mil Med Univ,2020,42(11):1109-1115.
点击复制

二甲双胍激活AMPK/mTOR通路上调阴茎海绵体自噬增强老年ED大鼠勃起功能(/HTML )
分享到:

《第三军医大学学报》[ISSN:1000-5404/CN:51-1095/R]

卷:
42卷
期数:
2020年第11期
页码:
1109-1115
栏目:
基础医学
出版日期:
2020-06-15

文章信息/Info

Title:
Metformin enhances erectile function in rats with aging-induced erectile dysfunction by activatingAMPK/mTOR pathway-regulated autophagy in corpus cavernosum
作者:
丁凡李宏伟欧阳勤吴小军
陆军军医大学(第三军医大学):附属第一医院泌尿外科,药学与检验医学系药物化学教研室
Author(s):
DING Fan LI Hongwei OUYANG Qin WU Xiaojun

Department of Urinary Surgery, First Affiliated Hospital, 2Department of Pharmaceutical Chemistry, Faculty of Pharmacy and Laboratory Medicine, Army Medical University (Third Military Medical University), Chongqing, 400038, China

关键词:
勃起功能障碍二甲双胍自噬AMPKmTOR
Keywords:
erectile dysfunction metformin autophagy AMPK mTOR
分类号:
R698.1; R965.2; R977.15
文献标志码:
A
摘要:

目的探讨二甲双胍对老年大鼠勃起功能的影响以及其对阴茎海绵体组织纤维化、自噬的调控和相关潜在机制。方法40只健康2月龄雄性SD大鼠等分为4组,阿朴吗啡(apomorphine,APO)阴茎勃起实验筛选老年勃起功能障碍(erectile dysfunction,ED)大鼠。A组(正常对照组)从2月龄时开始每日生理盐水灌胃2个月,无ED;B、C、D组为ED大鼠从18月龄时开始每日分别生理盐水灌胃(ED对照组)、二甲双胍(300 mg·kg-1·d-1)灌胃(二甲双胍组)、二甲双胍(300 mg·kg-1·d-1)灌胃同时腹腔注射compound C(0.2 mg·kg-1·d-1,二甲双胍+compound C组)2个月。电刺激测量勃起功能,Masson染色检测阴茎海绵体纤维化,Western blot、透射电镜检测自噬水平,免疫荧光、Western blot检测AMPK/mTOR通路蛋白表达。结果与正常对照组比较,ED对照组勃起功能明显降低(P<0.05),阴茎海绵体纤维化加重,自噬和AMPK/mTOR通路被抑制(P<0.05);二甲双胍组大鼠轻度恢复勃起功能(P<0.05),改善阴茎海绵体纤维化,上调自噬水平(P<0.05),激活AMPK/mTOR通路(P<0.05),以上指标仍未达到正常对照组水平(P<0.05);二甲双胍+compound C组与ED对照组差异无统计学意义(P>0.05)。结论二甲双胍能改善老年ED大鼠阴茎海绵体纤维化,增强勃起功能,其机制可能与激活AMPK/mTOR通路上调自噬有关。

Abstract:

ObjectiveTo investigate the effect of metformin on erectile function and its regulation on cavernous fibrosis and autophagy in aged rats, and explore the underlying mechanism. MethodsForty healthy 2-month-old male SD rats were randomly divided into groups A, B, C and D. APO at a dose of 100 mg/kg was injected intraperitoneally to the rats of the former group (at 2 months old) and of the latter 3 group (at 18 months old) to screen the rats with aging-induced erectile dysfunction. Those with ED from the latter 3 groups and those without ED in the group A were employed for the further studies. Group A (control group) was given intragastrical infusion of normal saline for 2 months from the age of 2 months. The rats of the latter 3 groups (18 months old) were injected inragastrically with normal saline, metformin at 300 mg·kg-1·d-1 alone and combined with 0.2 mg/kg compound C for 2 months, respectively. The erectile function was measured by electrical stimulation. The cavernous fibrosis was detected by Masson staining. The autophagy level was detected by Western blotting and transmission electron microscopy. The expression of AMPK/mTOR pathway related proteins was detected by immunofluorescence assay and Western blotting. ResultsCompared with the group A, the group B had significantly decreased erectile function (P<0.05), aggravated cavernous fibrosis, and inhibited autophagy and AMPK/mTOR pathway (P<0.05). Metformin treatment slightly restored the erectile function in the group C (P<0.05), alleviated the cavernous fibrosis, upregulated autophagy (P<0.05), and activated the AMPK/mTOR pathway (P<0.05). But these indicators still did not reach the levels of the group A (P<0.05). There were no significant differences in above indicators between group D and group B. ConclusionMetformin alleviates cavernous fibrosis and improves erectile function in aging-induced erectile dysfunction rats, which may be related to the activation of AMPK/mTOR pathway to up-regulate autophagy.

参考文献/References:

[1]KAYA E, SIKKA S C, KADOWITZ P J, et al. Aging and sexual health: getting to the problem[J]. Aging Male, 2017, 20 (2): 65-80. DOI:10.1080/13685538.2017.1295435.
[2]LEE M, SHARIFI R. Non-invasive management options for erectile dysfunction when a phosphodiesterase type 5 inhibitor fails[J]. Drugs Aging, 2018, 35(3): 175-187. DOI:10.1007/s40266-018-0528-4.
[3]YAFI F A, JENKINS L, ALBERSEN M, et al. Erectile dysfunction[J]. Nat Rev Dis, 2016, 2: 16003. DOI:10.1038/nrdp.2016.3.
[4]GALLUZZI L, GREEN D R. Autophagy-independent functions of the autophagy machinery[J]. Cell, 2019, 177(7): 1682-1699. DOI:10.1016/j.cell.2019.05.026.
[5]ZHANG J, WU X J, ZHUO D X, et al. Effect of tankyrase 1 on autophagy in the corpus cavernosum smooth muscle cells from ageing rats with erectile dysfunction and its potential mechanism[J]. Asian J Androl, 2010, 12 (5): 744-752. DOI:10.1038/aja.2010.44.
[6]BARZILAI N, CRANDALL J P, KRITCHEVSKY S B, et al. Metformin as a tool to target aging[J]. Cell Metab, 2016, 23 (6): 1060-1065. DOI:10.1016/j.cmet.2016.05.011.
[7]ZHANG Z, ZHANG H Y, ZHANG Y, et al. Inactivation of the Ras/MAPK/PPARγ signaling Axis alleviates diabetic mellitus-induced erectile dysfunction through suppression of corpus cavernosal endothelial cell apoptosis by inhibiting HMGCS2 expression[J]. Endocrine, 2019, 63(3): 615-631. DOI:10.1007/s12020-018-1810-2.
[8]SILVA F H, ALEXANDRE E C, CALMASINI F B, et al. Treatment with metformin improves erectile dysfunction in a murine model of obesity associated with insulin resistance[J]. Urology, 2015, 86(2): 423.e1-423.e6. DOI:10.1016/j.urology.2015.04.035.
[9]KIM Y M, KIM M Y, KIM H J, et al. Compound C independent of AMPK inhibits ICAM-1 and VCAM-1 expression in inflammatory stimulants-activated endothelial cells in vitro and in vivo[J]. Atherosclerosis, 2011, 219(1): 57-64. DOI:10.1016/j.atherosclerosis.2011.06.043.
[10]CHEN L, STAUBLI S E, SCHNEIDER M P, et al. Phosphodiesterase 5 inhibitors for the treatment of erectile dysfunction: a trade-off network meta-analysis[J]. Eur Urol, 2015, 68 (4): 674-680. DOI:10.1016/j.eururo.2015.03.031.
[11]ESCOBAR K A, COLE N H, MERMIER C M, et al. Autophagy and aging: Maintaining the proteome through exercise and caloric restriction[J]. Aging cell, 2019, 18(1): e12876. DOI:10.1111/acel.12876.
[12]TANG Z, CUI K, LUAN Y,et al. Human tissue kallikrein 1 ameliorates erectile function via modulation of macroautophagy in aged transgenic rats[J]. Andrology, 2018, 6(5): 766-774. DOI:10.1111/andr.12512.
[13]REN J, ZHANG Y. Targeting autophagy in aging and aging-related cardiovascular diseases[J]. Trends Pharmacol Sci, 2018, 39 (12): 1064-1076. DOI:10.1016/j.tips.2018.10.005.
[14]PATEL J P, LEE E H, MENA C I, et al. Effects of metformin on endothelial health and erectile dysfunction[J]. Transl Androl Urol, 2017, 6 (3): 556-565. DOI:10.21037/tau.2017.03.52.
[15]RANGARAJAN S, BONE N B, ZMIJEWSKA A A, et al. Metformin reverses established lung fibrosis in a bleomycin model[J]. Nat Med, 2018, 24 (8): 1121-1127. DOI:10.1038/s41591-018-0087-6.
[16]BAE J H, KIM J W, KWEON G R, et al. Corpus cavernosal smooth muscle relaxation effect of a novel AMPK activator, beta-lapachone[J]. J Sex Med, 2011, 8 (8): 2205-2214. DOI:10.1111/j.1743-6109.2010.01809.x.
[17]ZHU G Q, JEON S H, BAE W J, et al. Efficient promotion of autophagy and angiogenesis using mesenchymal stem cell therapy enhanced by the low-energy shock waves in the treatment of erectile dysfunction[J]. Stem cells Int, 2018, 2018: 1302672. DOI:10.1155/2018/1302672.

相似文献/References:

[1]卢薇,欧亚萍,梁英梅.二甲双胍对2型糖尿病患者血HS-CRP、TNF-α、ICAM-1水平的影响[J].第三军医大学学报,2008,30(18):1768.
[2]程莹,母义明,汪保安,等.二甲双胍减轻软脂酸诱导的血管内皮细胞损伤机制探讨[J].第三军医大学学报,2008,30(14):1357.
 CHENG Ying,MU Yi-ming,WANG Bao-an,et al.Protective mechanism of metformin in process of human umbilical vein endothelial cell injury induced by palmitic acid in vitro[J].J Third Mil Med Univ,2008,30(11):1357.
[3]李玉,彭颜晖.瑞格列奈联合二甲双胍治疗2型糖尿病疗效观察[J].第三军医大学学报,2009,31(18):1793.
[4]苏勇,王端,龙军,等.二甲双胍改善2型糖尿病合并舒张性心力衰竭患者心功能的临床研究[J].第三军医大学学报,2013,35(17):1862.
 Su Yong,Wang Duan,Long Jun,et al.Metformin improves heart function in patients having type 2 diabetes mellitus complicated with diastolic heart failure[J].J Third Mil Med Univ,2013,35(11):1862.
[5]石英,刘松青.复方盐酸二甲双胍片中格列本脲和二甲双胍溶出度的考察[J].第三军医大学学报,2005,27(11):1117.
[6]石英,刘松青,代青.LC-MS和HPLC法测定人血浆中格列本脲和二甲双胍方法的建立[J].第三军医大学学报,2005,27(08):731.
[7]章国亮,姜庆,江军.二甲双胍抑制IL-6诱导的LNCaP增殖及上皮-间质转化[J].第三军医大学学报,2013,35(13):1337.
 Zhang Guoliang,Jiang Qing,Jiang Jun.Metformin inhibits IL-6-induced LNCaP proliferation and epithelial-mesenchymal transition[J].J Third Mil Med Univ,2013,35(11):1337.
[8]张先祥,阳皓,杨刚毅,等.艾塞那肽与沙格列汀联合二甲双胍治疗2型糖尿病患者的疗效与安全性比较[J].第三军医大学学报,2013,35(14):1531.
 Zhang Xianxiang,Yang Hao,Yang Gangyi,et al.Efficacy and safety of exenatide versus saxagliptin combined with metformin in patients with type 2 diabetes mellitus[J].J Third Mil Med Univ,2013,35(11):1531.
[9]廖涌,黄健,孟平,等.胰岛素加二甲双胍治疗2型糖尿病疗效观察[J].第三军医大学学报,2003,25(11):0.[doi:10.16016/j.1000-5404.2003.11.027 ]
[10]黄颖 匡明杰 李云洁 赵僖格 钟馨桐 单敏慧 杨强 赵艳红.二甲双胍抑制骨细胞ROS产生及激活AKT信号通路改善糖皮质激素性骨质疏松[J].第三军医大学学报,2019,41(01):41.
 HUANG Ying,KUANG Mingjie,LI Yunjie,et al.Metfomin inhibits cellular reactive oxygen species and activates AKT signaling pathway to improve glucocorticoid-induced osteoporosis[J].J Third Mil Med Univ,2019,41(11):41.

更新日期/Last Update: 2020-05-30